Chemoinformaics analysis of HEXYL (E)-2-METHYLPENT-3-ENOATE
| Molecular Weight | 198.306 | nRot | 7 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
| Exact Molecular Weight | 198.162 | nRing | 0 |
| Solubility: LogS | -3.194 | nHRing | 0 |
| Solubility: LogP | 2.819 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 36.3134 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.72 |
| Synth | 1.592 |
| Natural Product Likeliness | 0.178 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.005 |
| CACO-2 | -4.511 |
| MDCK | 0.0000215 |
| BBB | 0.566 |
| PPB | 0.747091 |
| VDSS | 0.488 |
| FU | 0.246409 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.631 |
| CYP2c19-inh | 0.825 |
| CYP2c19-sub | 0.138 |
| CYP2c9-inh | 0.573 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.282 |
| CYP2d6-sub | 0.606 |
| CYP3a4-inh | 0.093 |
| CYP3a4-sub | 0.215 |
| CL | 11.326 |
| T12 | 0.865 |
| hERG | 0.048 |
| Ames | 0.132 |
| ROA | 0.837 |
| SkinSen | 0.439 |
| Carcinogencity | 0.396 |
| EI | 0.987 |
| Respiratory | 0.171 |
| NR-Aromatase | 0.045 |
| Antiviral | Yes |
| Prediction | 0.610584 |